Neurogene Inc.
NGN-401
Rett Syndrome
Date
TBD
Approval decision · Date TBD estimated
What's at stake
A final FDA approval decision on NGN-401 for Rett Syndrome is expected Date TBD.
Primary source
· SEC 8-K
verified 13h ago
“the likelihood of gaining approval of NGN-401 from the U.S. Food and Drug Administration (FDA) or any other regulator;”